| For: | Niu S, Chen SC, Wang CX, Yue L, Wang SQ. Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice. World J Hepatol 2025; 17(10): 110402 [PMID: 41179732 DOI: 10.4254/wjh.v17.i10.110402] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i10/110402.htm |
| Number | Citing Articles |
| 1 |
Farima Farsi, Dorsa Ghorban Sarvi, Mohammadmahdi Abbasi, Shirin Hasani-Ranjbar, Suraiya Saleem. Empagliflozin in the Absence of Diabetes: A Systematic Review of Its Anthropometric and Metabolic Effects in Humans and Animals. International Journal of Endocrinology 2026; 2026(1) doi: 10.1155/ije/5558442
|